JACC
HOME SUBSCRIPTIONS CURRENT ISSUE PAST ISSUES CARDIOSOURCE SEARCH HELP FEEDBACK
 QUICK SEARCH:   [advanced]


     


J Am Coll Cardiol, 2001; 38:1628-1632
© 2001 by the American College of Cardiology Foundation
This Article
Right arrow Abstract Freely available
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ai, M.
Right arrow Articles by Reaven, G. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ai, M.
Right arrow Articles by Reaven, G. M.

Relationship between plasma insulin concentration and plasma remnant lipoprotein response to an oral fat load in patients with type 2 diabetes

Masumi Ai, MD*, Akira Tanaka, MD*,*, Keiko Ogita, MD{dagger}, Masaaki Sekinc, MD{dagger}, Fujie Numano, MD{dagger}, Fujio Numano, MD* and Gerald M. Reaven, MD{ddagger}

* Third Department of Internal Medicine, Tokyo Medical and Dental University, Tokyo, Japan
{dagger} Department of Internal Medicine, Tokyo Metropolitan Kiyose Hospital, Tokyo, Japan
{ddagger} Department of Medicine, Stanford University School of Medicine, Stanford, California, USA



View larger version (15K):

[in a new window]
 
Figure 1 Plasma glucose and insulin concentrations before and after a 75 g oral glucose load in hyperinsulinemic patients with type 2 diabetes (H-DM) and normoinsulinemic patients with type 2 diabetes (N-DM) .

 


View larger version (20K):

[in a new window]
 
Figure 2 Plasma triglyceride, remnant lipoprotein triglyceride (RLP-TG) and remnant lipoprotein cholesterol (RLP-C) concentrations before and after an oral fat load in normal volunteers (CTL) and in hyperinsulinemic patients with type 2 diabetes (H-DM) and normoinsulinemic patients with type 2 diabetes (N-DM).

 





HOME SUBSCRIPTIONS CURRENT ISSUE PAST ISSUES CARDIOSOURCE SEARCH HELP FEEDBACK
Copyright © 2001 by the American College of Cardiology Foundation.